Genomic mammary Amyloid a sequence

Details Genomic mammary Amyloid a sequence Genomic mammary Amyloid a sequence

2007-05-08

2007-05-08

Carlson, Karen Cochrane (Department: 1656)

Chemistry: molecular biology and microbiology

Micro-organism, tissue cell culture or enzyme using process...

Recombinant dna technique included in method of making a...

C435S252300, C435S325000, C435S320100, C536S023100, C530S350000

Reexamination Certificate

active

10116788

ABSTRACT:
A genomic nucleotide sequence encoding Serum Amyloid A (SAA), isolated and purified from mammalian colostrum, is disclosed. Methods of use for the same in transgenic protocols is also disclosed.

REFERENCES:
patent: 4377569 (1983-03-01), Plymate
patent: 4425330 (1984-01-01), Norcross et al.
patent: 4755380 (1988-07-01), Grubb
patent: 4952496 (1990-08-01), Studier
patent: 5227301 (1993-07-01), Turner et al.
patent: 5536640 (1996-07-01), Sipe et al.
patent: 5585098 (1996-12-01), Coleman
patent: 5700465 (1997-12-01), Tao et al.
patent: 5807684 (1998-09-01), Simmons
patent: 5853985 (1998-12-01), Salbaum
patent: 5952313 (1999-09-01), Carlson
patent: 5958883 (1999-09-01), Snow
patent: 6004936 (1999-12-01), Kisilevsky
patent: 6013857 (2000-01-01), Deboer
patent: 0872 558 (1998-10-01), None
patent: 1 067 194 (2001-01-01), None
patent: WO/95/21625 (1995-08-01), None
patent: WO/97/04317 (1997-02-01), None
patent: WO/97/06184 (1997-02-01), None
patent: WO/98/03206 (1998-01-01), None
patent: WO/98/40506 (1998-09-01), None
patent: WO/99/18227 (1999-04-01), None
patent: WO 01 14580 (2001-03-01), None
patent: WO/01/31006 (2001-03-01), None
Bauman, H., et al., “The acute phase response”, IT Review, 1994 Elsevier Science Ltd., 0167-5699/94.
Hulten, C., et al., “The acute phase serum amyloid A protein (SAA) in the horse: isolation and characterization of three isoforms”, Veterinary Immunology and Immunopathology 57(1997) 215-227.
Jensen, L., et al., “Regulation of serum amyloid A protein expression during the acute-phase response”, Biochem J. (1998) 334:489-503.
Kho Y.J., et al., “Cloning and characterization of involution-specific genes from the bovine mammary gland” Database EMBL accession No. AF160867 ′Online! Jun. 30, 2000.
Kho, Y.J., et al., GenBank Submission AAF77630, serum amyloid A protein [Bos tauru].
Liang, Jun-shan, et al., “Amino terminao region of acute phase, but not constitutive, serym amyloid A (apoSAA) specifically binds and transports cholesterol into aortic smooth muscle and HepG2 cells”, Journal of Lipid Research (1996) 37:2109-2116.
Liepnieks, J., et al., “The primary structure of serum amyloid A protein in the rabbit: Comparison with serum amyloid A proteins in other species”, J Lab Clin Med (1991) 118(6):570-576.
Malle, E., “Human serum amyloid A (SSA) protein: a prominent acute-phase reactant for clinical practice”, European Journal of Clinical Investigation (1996) 26::427-435.
McDonald, T., et al., “A monoclonal antibody sandwich immunoassay for serum amyloid A (SAA) protein”, J. of Immunological Methods, 144 (1991) 149-155.
Migita, K., et al., “Serum Amyloid A Protein Induces Production of Matrix Metalloproteinases by Human Synovial Fibroblasts”, Laboratory Investigation, 78(5):535-539 (1998).
Mitchell, T., et al., “The acute phase reactant serum amyloid A (SAA3) is a novel substrate for degradation by the metalloproteinases collagenase and stromelysin”, Biochem et Biophysica Acta. 1156 (1998) 245-254.
Mitchell, T.I., et al., “Serum Amyloid A (SAA3) Produced by Rabbit Synovial Fibroblasts Treated with Phorbol Esters or Interleukin 1 induces Synthesis of Collagenase and is Neutralized with Specific Antiserum”,J. Clinical Investigation87(4):1177-1185 (1991).
Patel, H., “Human Serium Amyloid A has Cytokine-Like Properties”, Scand. J. Immunol. 1998, 48:410-418.
Peristeris, P., “Effects of serum amyloid A protein on lymphocytes, HeLa, and MRC5 cells in culture”, Biochem. Cell Biol., (1989) 67:365-370.
Rossevatn, K., et al., “The complete amino acid sequence of bovine serum amyloid protein A (SAA) and of subspecies of the tissue-deposited amyloid fibril protein A”,Scand. J. Immunol. 35(2):217-24 (1992).
Sletten, K., “The Primary Structure of Equine Serum Amyloid A (SAA) Protein”,Scand. J. Immunol. 30(1):117-122 (1989).
Smith, J., et al., “Comparison of Serum Amyloid A and C-Reactive Protein as Indicators of Lung Inflammation in Corticosteroid Treated and Non-Corticosteroid Treated Cystic Fibrosis Patients”, Journal of Clinical Laboratory Analysis 6:219-224 (1992).
Smith, J., et al., “Production of serum amyloid A and C-reactive Protein by HepG2 cells stimulated with combinations of cytokines or monocyte conditioned media: the effects of prednisolone”, Clin. exp. Immunol. (1992) 783.
Smith, J., et al., “Use of Ethanol-Eluted Hydrophobic Interaction Chromatography in the Purification of Serum Amyloid A”, Protein Expression and Purification 2:158-161 (1991).
Steel, D., et al., “Expression and regulation of Constitutive and Acute Phase Serum Amyloid A mRNAs in Hepatic and Non-Hepatic Cell Lines”, 1996, Blackwell Science Ltd., Scandinavian Journal of Immunology, 44:493-500.
Steel, D., et al., “The major acute phase reactants: C-reactive protein, serum amyloid P component and serum and amyloid A protein”, Review, 1994 Elsevier Science Ltd, 0167-5699/94.
Thompson, D., et al., “The value of acute phase protein measurements in clinical practice”, Ann Clin Biochem 1992, 29:123-131.
Uhlar, C., “Evolution of the Serum Amyloid A (SAA) Protein Superfamily”, Genomics 19:228-235 (1994).
Urieli-Shoval, S., et al., “Widespread Expression of Serum Amyloid A in Histologically Normal Human Tissues: Predominant Localization of the Epithelium”, The Journal of Histochemistry & Cytochemistry 46(12):1377-1384 (1998).
Zimlichman, S., “Serum amyloid A, an acute phase protein, inhibits platelet activation”, Serum amyloid A and platelet activation, 116(2):180-186.
Benson et al., “A unique insertion in the primary structure of bovine amyloid AA protein”, J. Lab ClinMed, vol. 113, pp. 67-72, 1989.
Hirvonen, et al., “Acute phase Response in Heifers with Experimentally Induce Mastitis”, J. of Dairy Res., 63:351-360, 1996.
Huszenicza, et al., “Diagnostic value of certain mastitis markers in following up the clinical and bacteriological changes in pharmacotherapeutic studies”, Acta Veterinaria Hungarica 45(4):409-416, 1997.
Kho et al., “Rapid Communication: Cloning of bovine serum amyloid A3 cDNA1”, American Society of Animal Science, May 19, 2000.
Kluve-Beckerman et al., “Human serum amyloid A—Three Hepatic mRNAs and the corresponding proteins in one person”, The Journal of Clinical Investigation, vol. 82, pp. 1670-1675, 1988.
Kluve-Beckerman et al., “Primary structures of dog and cat amyloid A proteins: comparison to Human AA”, Comp. Biochem Physiol. B, vol. 94, pp. 175-183, 1989.
Kluve-Beckerman et al., “Sequence Analysis of a Third Human SAA gene”, Database CAPLUS on STN, meeting abstract, 1991.
Larson et al., “Human serum amyloid A3 peptide enhances intestinal MUC3 expression and inhibits EPEC adherence”, pp. 531-540, Biochemical and Biophysical Research Communications 300, Elsevier Science, 2002.
Larson et al., “Induction of human mammary-associated serum amyloid A3 expression by prolactin od lipopolysaccharide”, pp. 1030-1037, Biochemical and Biophysical Research Communications 301, Elsevier Science, 2003.
McDonald et al., “Elevated extrahepatic expression and secretion of mammary-associate serum amyloid A3 (M-SAA3) into colostrums”, Veterinary Immunology and Immunopathology 6528, 2001.
Marhaug et al., “Mink serum amyloid A protein. Expression and primary structure based on cDNA”, J. Biol. Chem., vol. 265, 10049-10054, 1990.
Newstead, D.F., Acceptable levels of bovine immunoglobin in colostrums testing:, New Zealand Journal of Dairy science and Technology, vol. 6, No. 2, p. 2, Xp008036075, 1971.
Nielsen et al., “Acute phase protein concentrations in serum and milk from healthy cows, coes with clinical mastitis and cows with extramammary inflammatory conditions”, The Veterinary Record, vol.

Affiliated with

Also associated with

Rating

Genomic mammary Amyloid a sequence does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Genomic mammary Amyloid a sequence, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Genomic mammary Amyloid a sequence will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3787051